Lv4
710 积分 2022-08-25 加入
The catastrophic costs of chronic kidney disease
27天前
已完结
Autosomal Dominant Polycystic Kidney Disease: A Review
1个月前
已完结
Autosomal Dominant Polycystic Kidney Disease
1个月前
已关闭
Genotype-Based Molecular Mechanisms in Alport Syndrome
1个月前
已完结
Pharmacological Targeting of Mitochondria in Diabetic Kidney Disease
1个月前
已完结
Combination therapy for kidney disease in people with diabetes mellitus
1个月前
已完结
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review
1个月前
已完结
Mechanisms of diabetic kidney disease and established and emerging treatments
1个月前
已完结
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
2个月前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
